Feed Additives … ENZYMES Quantum® Blue is the proven solution Optimised for maximum phytate destruction, Quantum®
for your business than any other phytase. Quantum®
AB VISTA Quantum Blue superdosing and Econase XT to improve animal performance
Quantum Blue phytase superdosing has been in commercial use for several years. The goal of superdosing is to improve animal performance by reducing the anti-nutritive effects of phytate through a higher dosage of Quantum Blue phytase than would be required for the expected mineral release. Superdosing can improve performance in both pigs and poultry,
and the majority of trials have been made with piglets and broilers. Subsequent trials have also shown performance improvements in growing-finishing pigs. More recently, positive results of Quantum Blue superdosing
were seen under commercial conditions with broilers in the UK, corroborating the international results in the scientific database. These commercial results have shown improvements in animal performance (gain and FCR) and also better litter quality, leading to a reduction in pododermatitis. A composite analysis of 10 broiler trials, performed in different
countries, testing the combination of Econase XT (an intrinsically thermostable xylanase product) and Quantum Blue superdosing, showed an improvement of 6 points in weight-corrected FCR when compared to birds that received diets with standard dose of phytase and no xylanase. Improvements in litter quality and pododermatitis scores seen under experimental conditions have subsequently been confirmed in commercial trials. Both products can be applied either as dry products in the mixer
or as liquids after pelleting, and activity of each product in the feed can be determined quickly by using ELISA technology.
For further information, please contact: E:
emea@abvista.com, T: +44 (0)1672 517664 W:
www.abvista.com
Blue unlocks more value Blue offers a revolution in phytase performance
• Greater phosphorus release • Unrivalled intrinsic thermostability • Find out more: E:
quantumblue@abvista.com T: +44 (0)1672 517664 W: a
ADISSEO Improving the efficiency of corn-soy diets for poultry with feedase
The NSP content of feed ingredients NSPs are the main constituents of plant cell walls and play a role in the encapsulation of nutrients, including amino acids, starch and lipids. It is well known that NSPs negatively affect access of endogenously secreted enzymes to their substrates, reducing digestibility. The major difference between corn and wheat NSPs is the kind of arabinoxylan structures present in each. Arabinoxylans from corn have a much more complex structure than arabinoxylans from wheat. They are highly branched with multiple arabinose residue substitutions in corn.
The feedase effect The ability of efficient multi-enzyme solutions to improve global feed digestibility is known as the feedase effect. By reducing the indigestible fraction of feed, as well as anti-nutritional factors, more nutrients are released. This is due to the inclusion of a wide range of NSP-degrading enzymes, including xylanases and arabinofuranosidases (ABFs). ABFs are debranching enzymes; they improve the enzymatic
activity of carbohydrases on the arabinose side chains of arabinoxylans. By working synergistically, NSP breakdown is increased and the anti- nutritional effects are therefore reduced - boosting an overall efficacy of feed energy utilization. At the same time the release of other nutrients is increased, such as amino acids and lipids. The feedase effect on corn –soy diets allows both larger energy
and dAA uplifts - hence greater feed cost savings and higher profitability in poultry production.
Andrew.mcinerney@
adisseo.com Websites:
Feedsolutions.adisseo.com
ANPARIO Enzymes to maximise gut health Anpario has a range of enzyme solutions developed with feed performance in mind. Our aim
www.adisseo.com
Phytate is compromising your feed performance Phytate anti-nutrient effects could be costing you £4 per tonne in lost performance.
Enhancing nature through science™
PAGE 46 MAY/JUNE 2018 FEED COMPOUNDER
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68